2010
DOI: 10.1016/j.jtcvs.2009.05.047
|View full text |Cite
|
Sign up to set email alerts
|

The unidirectional valve patch provides no benefits to early and long-term survival in patients with ventricular septal defect and severe pulmonary artery hypertension

Abstract: A unidirectional valve patch provides no benefits to early and long-term survival when it is used to deal with ventricular septal defect and severe pulmonary artery hypertension.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 15 publications
(14 reference statements)
0
3
1
Order By: Relevance
“…We expect to shortly provide more data in this direction. Our findings are in sharp contrast to a recent study from China [15] in which 876 patients with VSD and PAH underwent VSD closure. In 195 of these, a UVP was used to close the VSD.…”
Section: Discussioncontrasting
confidence: 99%
“…We expect to shortly provide more data in this direction. Our findings are in sharp contrast to a recent study from China [15] in which 876 patients with VSD and PAH underwent VSD closure. In 195 of these, a UVP was used to close the VSD.…”
Section: Discussioncontrasting
confidence: 99%
“…Today, two main surgical strategies, a unidirectional valve patch and a simple patch are used in these patients. Gan and colleagues 6 emphasized that a unidirectional valve patch provides no benefits in terms of early or long-term survival, whereas some authors have reported better early results in children and adults with increased PVR. 1 , 3…”
Section: Discussionmentioning
confidence: 99%
“…In addition, Eisenmenger syndrome is more likely to develop in patients with large aortopulmonary or interventricular shunts [11]. While there are some data regarding surgical repair for PAH-CHD in adults, very little is known about the long-term outcome of defect closure in this patient group [12,13,14].…”
Section: Discussionmentioning
confidence: 99%